BACKGROUND: Freezing of gait (FOG) in Parkinson disease (PD) may involve executive dysfunction. This study examined whether executive functioning and attention are more affected in patients with FOG compared with those without and determined whether these processes are influenced by anti-Parkinson medication. METHODS: A total of 11 PD patients with FOG, 11 without FOG, and 10 healthy control subjects, matched for age, gender, and education, participated. General motor, mental and cognitive screening tests, as well as specific neuropsychological assessment of executive functions and the Attention Network Test (ANT) were administered. The ANT was conducted in both ON and OFF phases in a counterbalanced design to determine medication-specific effects. RESULTS: FOG showed a clear association with impairment in the executive control network for conflict resolution (inhibition of unwanted responses and impaired response selection), compared with nonfreezers and healthy controls, F(2, 28) = 5.41, P = .01. Orienting and alerting function did not differ between groups, F < 1. Other executive functions, such as abstract problem solving and mental flexibility were not associated with FOG (P > .10). Anti-Parkinson medication did not ameliorate conflict resolution (P > .10), although orienting attention improved with medication, F(1, 17) = 9.81, P < .01. CONCLUSIONS: This study shows an association between impaired conflict resolution and FOG, important in understanding the interplay between cognitive and motor problems, which can lead to specific rehabilitation strategies.
BACKGROUND: Freezing of gait (FOG) in Parkinson disease (PD) may involve executive dysfunction. This study examined whether executive functioning and attention are more affected in patients with FOG compared with those without and determined whether these processes are influenced by anti-Parkinson medication. METHODS: A total of 11 PDpatients with FOG, 11 without FOG, and 10 healthy control subjects, matched for age, gender, and education, participated. General motor, mental and cognitive screening tests, as well as specific neuropsychological assessment of executive functions and the Attention Network Test (ANT) were administered. The ANT was conducted in both ON and OFF phases in a counterbalanced design to determine medication-specific effects. RESULTS:FOG showed a clear association with impairment in the executive control network for conflict resolution (inhibition of unwanted responses and impaired response selection), compared with nonfreezers and healthy controls, F(2, 28) = 5.41, P = .01. Orienting and alerting function did not differ between groups, F < 1. Other executive functions, such as abstract problem solving and mental flexibility were not associated with FOG (P > .10). Anti-Parkinson medication did not ameliorate conflict resolution (P > .10), although orienting attention improved with medication, F(1, 17) = 9.81, P < .01. CONCLUSIONS: This study shows an association between impaired conflict resolution and FOG, important in understanding the interplay between cognitive and motor problems, which can lead to specific rehabilitation strategies.
Authors: Elie Matar; James M Shine; Moran Gilat; Kaylena A Ehgoetz Martens; Philip B Ward; Michael J Frank; Ahmed A Moustafa; Sharon L Naismith; Simon J G Lewis Journal: Hum Brain Mapp Date: 2019-01-13 Impact factor: 5.038
Authors: Courtney C Walton; James M Shine; Loren Mowszowski; Moran Gilat; Julie M Hall; Claire O'Callaghan; Sharon L Naismith; Simon J G Lewis Journal: J Neural Transm (Vienna) Date: 2014-07-22 Impact factor: 3.575
Authors: Senja H G Mensink; Jorik Nonnekes; Geert van Bon; Anke H Snijders; Jacques Duysens; Vivian Weerdesteyn; Bastiaan R Bloem; Lars B Oude Nijhuis Journal: J Neurol Date: 2014-05 Impact factor: 4.849
Authors: Conor Fearon; John S Butler; Saskia M Waechter; Isabelle Killane; Simon P Kelly; Richard B Reilly; Timothy Lynch Journal: Exp Brain Res Date: 2020-11-02 Impact factor: 1.972
Authors: Elke Heremans; A Nieuwboer; J Spildooren; J Vandenbossche; N Deroost; E Soetens; E Kerckhofs; S Vercruysse Journal: J Neural Transm (Vienna) Date: 2013-01-18 Impact factor: 3.575